Understanding immune responses to develop vaccines and treatments for infectious diseases
TASK A-1: NIH TETRAMER CORE FACILITY (INFECTIOUS DISEASES OTHER THAN HIV/AIDS)
['FUNDING_OTHER'] · EMORY UNIVERSITY · NIH-10812212
This study is all about learning how our immune system fights infections so we can create better vaccines and treatments, and it's designed for researchers who want to improve health for everyone.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-10812212 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing our understanding of how the immune system responds to infectious diseases, which is crucial for developing effective vaccines and therapeutic agents. The National Institute of Allergy and Infectious Diseases (NIAID) supports the MHC Tetramer Core facility, which synthesizes and distributes specialized reagents that help researchers study immune responses. By providing these resources, the research aims to improve public health outcomes related to infectious and immune-mediated diseases.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by infectious diseases or those at risk of such diseases.
Not a fit: Patients with non-infectious diseases or those not involved in the immune response may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new vaccines and treatments that significantly improve patient outcomes for various infectious diseases.
How similar studies have performed: Previous research has shown success in similar approaches, particularly in the development of vaccines and therapies for infectious diseases using immune response understanding.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ALTMAN, JOHN — EMORY UNIVERSITY
- Study coordinator: ALTMAN, JOHN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases, Infectious Disease Pathway, Infectious Diseases, Infectious Disorder, Disease